Exciting News: FDA Has Approved New Alzheimer's Treatment

A message from the CEO of the Alzheimer's Association regarding an exciting new Alzheimer's treatment. 

"The Alzheimer’s Association welcomes and celebrates today’s historic Food and Drug Administration (FDA) approval of aducanumab for the treatment of Alzheimer’s disease.

 

While certainly not a cure, this is the first ever FDA-approved treatment for the underlying biology of Alzheimer’s, not just the symptoms. Slowing progression for those with Mild Cognitive Impairment (MCI) due to Alzheimer’s disease or Alzheimer’s dementia in its earliest stage offers the potential for more precious time for diagnosed individuals and their loved ones.

 

This new treatment approval and sustained progress in the research field benefit from years of investment and relentless dedication to our vision of a world without Alzheimer's and all other dementia.

 

The advances the Alzheimer’s Association has been able to drive on behalf of our constituents, to bring us to this historic moment, are thanks to you and others who have been so supportive. I am deeply grateful to you for the role you have played to make this day possible. Thank you!

 

With your support, the Alzheimer’s Association has advanced research in many ways, including directly funding the tools for early detection that have facilitated development of new treatments.

 

Of course, as I’m sure you realize, our work is not done. The fight to end Alzheimer’s is as urgent as ever. As the leader in the quest to end Alzheimer’s and all other dementia, you can be assured that the Alzheimer’s Association will fight to ensure access to this treatment and ultimately others for all communities. We won’t stop until the day our vision becomes reality for everyone.

 

Sincerely,

Harry Johns
Chief Executive Officer

 

If you or a loved one is experiencing memory changes, the Alzheimer’s Association strongly encourages speaking with a health care provider for a thorough evaluation, diagnosis and to discuss treatment options. Visit the Alzheimer’s Association at alz.org, or reach our Helpline 24/7 at 800.272.3900. "